QMI

Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna

产品代码
QMI
器械名称
Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna
管理类别
第 2 类(Class II)
21 CFR 条款
21 CFR 866.3183
FDA 专业组
Microbiology
上市路径
需提交 510(k) 上市前通告
该代码近三年的 510(k)
1 件
其中 Summary 已存档
1 份,可直接下载
FDA 历史累计 510(k)
2 件(全部年份;本站只收录近三年的明细)

FDA 分类定义

An in vitro nucleic acid amplification test for the quantitation of BK virus (BKV) DNA in human samples intended for use as an aid in the management of BKV in transplant patients. In patients undergoing monitoring of BKV, serial DNA measurements can be used to indicate the need for potential treatment changes and to assess viral response to treatment. Test results are intended to be read and analyzed by a qualified licensed healthcare professional in conjunction with clinical signs and symptoms and relevant laboratory findings. Test results must not be the sole basis for patient management decisions.

定义原文来自 FDA 器械分类库,属美国联邦政府作品(公有领域)。

该代码近三年的 510(k)(1 件)

数据窗口为最近三年。最新一件:2025-03-24。

510(k) 号批准日期申请人器械名称摘要
K2419212025-03-24Abbott Molecular, Inc.Alinity m BKVPDF

其中 1 件的 Summary 已存档在本站,点 PDF 直接下载;其余给 FDA 官方链接。

FDA 官方分类页: QMI
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。